Pharma Major Lupin Limited (Lupin) announced today that its US subsidiary, Lupin Pharmaceuticals Inc. has launched its Donepezil Hydrochloride Tablets, 23 mg having received approval from the United States Food and Drug Administration (FDA) earlier to market a generic equivalent of Eisai Inc’s Aricept® Tablets, 23mg.
{iframe}http://www.lupin.com/lupin-launches-generic-aricept-tablets-in-the-us.php?utm_source=BioHealth+and+Life+Sciences+Update+-+4%2F15%2F16&utm_campaign=4-15&utm_medium=email{/iframe}